EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Smart multi‐functional aggregates reoxygenate tumor microenvironment through a two‐pronged strategy to revitalize cancer immunotherapy

Yan Zhang, Luoqi Liang, Hexiang Li, Yuqing Cao, Du Meng, Xinru Li, Meichen Wang, Jingyuan Wang, Yao Yao, Shaoqiang Zhang, Chao Chen, Peng Hou and 1 more

Aggregate · 2024-08 · 5 (4)

DOI: 10.1002/agt2.545 ↗

At a glance

Journal article in Aggregate, published online on 2024-03-20. Written by Yan Zhang and 12 co-authors. Cited 13 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

PD‐1/PD‐L1 inhibitors have emerged as standard treatments for advanced solid tumors; however, challenges such as a low overall response rate and systemic side effects impede their implementation. Hypoxia drives the remodeling of the tumor microenvironment, which is a leading reason for the failure of immunotherapies. Despite some reported strategies to alleviate hypoxia, their individual limitations constrain further improvements. Herein, a novel two‐pronged strategy is presented to efficiently address hypoxia by simultaneously adopting atovaquone (ATO, inhibiting oxygen consumption) and oxyhemoglobin (HbO 2 , directly supplementing oxygen) within a multifunctional aggregate termed NPs‐aPD‐1/HbO 2 /ATO. In addition to eliminating hypoxia with these two components, this smart aggregate also includes albumin and an ROS‐responsive cross‐linker as a controlled release scaffold, along with PD‐1 antibody (aPD‐1) for immunotherapy. Intriguingly, NPs‐aPD‐1/HbO 2 /ATO demonstrates exceptional tumor targeting in vivo, exhibiting ≈4.2 fold higher accumulation in tumors than in the liver. Consequently, this aggregate not only effectively mitigates hypoxia and significantly assists aPD‐1 immunotherapy but also simultaneously resolves the targeting and systemic toxicity issues associated with individual administration of each component. This study proposes substantial implications for drug‐targeted delivery, addressing tumor hypoxia and advancing immunotherapy, providing valuable insights for advancing cancer treatment strategies.

Cite

APA

Zhang, Y., Liang, L., Li, H., Cao, Y., Meng, D., Li, X., Wang, M., Wang, J., Yao, Y., Zhang, S., Chen, C., Hou, P., & Yang, Q. (2024). Smart multi‐functional aggregates reoxygenate tumor microenvironment through a two‐pronged strategy to revitalize cancer immunotherapy. Aggregate, 5(4). https://doi.org/10.1002/agt2.545

Vancouver

Zhang Y, Liang L, Li H, Cao Y, Meng D, Li X, et al. Smart multi‐functional aggregates reoxygenate tumor microenvironment through a two‐pronged strategy to revitalize cancer immunotherapy. Aggregate. 2024;5(4). doi:10.1002/agt2.545

BibTeX
@article{Zhang2024,
  author = {Zhang, Yan and Liang, Luoqi and Li, Hexiang and Cao, Yuqing and Meng, Du and Li, Xinru and Wang, Meichen and Wang, Jingyuan and Yao, Yao and Zhang, Shaoqiang and Chen, Chao and Hou, Peng and Yang, Qi},
  title = {Smart multi‐functional aggregates reoxygenate tumor microenvironment through a two‐pronged strategy to revitalize cancer immunotherapy},
  journal = {Aggregate},
  year = {2024},
  volume = {5},
  number = {4},
  doi = {10.1002/agt2.545}
}
Start for free →